Ponka P, Richardson D R, Edward J T, Chubb F L
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montréal, QC Canada.
Can J Physiol Pharmacol. 1994 Jun;72(6):659-66. doi: 10.1139/y94-093.
Analogues of the iron (III) chelator, pyridoxal isonicotinoyl hydrazone (PIH) show high potential as orally active agents for the treatment of iron-overload diseases, such as thalassemia. In the present study, the n-octanol-water partition coefficients of 30 analogues of PIH were measured by thin-layer chromatography and also calculated using the additive schemes of Rekker. The purpose was to examine the relationship between lipophilicity of the apochelator and its ability to promote the release of 59Fe from reticulocytes loaded with nonheme 59Fe. Interestingly, maximum activity occurred when the partition coefficient of the apochelator was approximately 1 (log P = 0). Considering the results in the context of the design and synthesis of more active analogues of PIH, it can be suggested that before initiating synthesis, a useful indication of biological activity can be determined by examining the lipophilicity of the molecule, using the schemes of Rekker to calculate the partition coefficient. By using this strategy, analogues of PIH with inappropriate lipophilicity can be excluded before initiating the expensive process of screening in biological models.
铁(III)螯合剂吡啶醛异烟酰腙(PIH)的类似物作为治疗铁过载疾病(如地中海贫血)的口服活性剂显示出很高的潜力。在本研究中,通过薄层色谱法测量了30种PIH类似物的正辛醇-水分配系数,并使用Rekker的加和方案进行了计算。目的是研究脱铁螯合剂的亲脂性与其促进负载非血红素59Fe的网织红细胞释放59Fe能力之间的关系。有趣的是,当脱铁螯合剂的分配系数约为1(log P = 0)时,活性达到最大值。结合设计和合成更具活性的PIH类似物的背景来考虑这些结果,可以提出在开始合成之前,通过使用Rekker方案计算分配系数来检测分子的亲脂性,可作为生物活性的有用指标。通过使用这种策略,在启动昂贵的生物模型筛选过程之前,可以排除亲脂性不合适的PIH类似物。